Welcome and Introduction and Keynotes

Speaker(s):

• Thomas B. Hartman, President and CEO, ISPE
• Antonio R. Moreira, PhD, Vice Provost, Academic Affairs, University of Maryland, Baltimore County
• Wilson W. Bryan, M.D., Director, Office of Tissues and Advanced Therapies, CBER/FDA
• Francesco Cicirello, Director, Quality Assurance, Evelo Biosciences
• Richard Denk, Senior Consultant Aseptic Processing & Containment, SKAN AG
• Matthew J. Davis, Senior GMP Inspector, Therapeutic Goods Administration
• Rino Rappuoli, Chief Scientist and Head External R&D, GSK Vaccines
• Jessica Beyer, Director, Cell Therapy Manufacturing, Bristol Myers Squibb
• Carolyn Laurencot, Associate Director for Regulatory Science and Review, Division of Cellular & G, FDA (US Food and Drug Administration)
• Oliver Hennig, Senior Vice President Operations, BioNTech SE
• Sandy Douglas, Academic Clinician, University of Oxford